Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab

NCT02000102 · clinicaltrials.gov ↗

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Intravitreal Injection of Aflibercept

Sponsor

Stanford University